• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样纤维形成背后的人溶菌酶变体的不稳定性、解折叠和聚集。

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.

作者信息

Booth D R, Sunde M, Bellotti V, Robinson C V, Hutchinson W L, Fraser P E, Hawkins P N, Dobson C M, Radford S E, Blake C C, Pepys M B

机构信息

Immunological Medicine Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Nature. 1997 Feb 27;385(6619):787-93. doi: 10.1038/385787a0.

DOI:10.1038/385787a0
PMID:9039909
Abstract

Tissue deposition of soluble proteins as amyloid fibrils underlies a range of fatal diseases. The two naturally occurring human lysozyme variants are both amyloidogenic, and are shown here to be unstable. They aggregate to form amyloid fibrils with transformation of the mainly helical native fold, observed in crystal structures, to the amyloid fibril cross-beta fold. Biophysical studies suggest that partly folded intermediates are involved in fibrillogenesis, and this may be relevant to amyloidosis generally.

摘要

可溶性蛋白质以淀粉样纤维形式在组织中沉积是一系列致命疾病的基础。两种天然存在的人溶菌酶变体都具有淀粉样变性,并且在此显示为不稳定的。它们聚集形成淀粉样纤维,同时晶体结构中观察到的主要为螺旋状的天然折叠转变为淀粉样纤维的交叉β折叠。生物物理研究表明,部分折叠的中间体参与了纤维形成过程,这可能与一般的淀粉样变性有关。

相似文献

1
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.淀粉样纤维形成背后的人溶菌酶变体的不稳定性、解折叠和聚集。
Nature. 1997 Feb 27;385(6619):787-93. doi: 10.1038/385787a0.
2
Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.人溶菌酶折叠的机制研究及其疾病相关变体中淀粉样生成行为的起源。
Biochemistry. 1999 May 18;38(20):6419-27. doi: 10.1021/bi983037t.
3
Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.野生型人溶菌酶及其疾病相关突变变体的淀粉样纤维形成与种子化
J Struct Biol. 2000 Jun;130(2-3):339-51. doi: 10.1006/jsbi.2000.4264.
4
A highly amyloidogenic region of hen lysozyme.鸡溶菌酶的一个高度淀粉样蛋白生成区域。
J Mol Biol. 2004 Jul 23;340(5):1153-65. doi: 10.1016/j.jmb.2004.05.056.
5
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.解析溶菌酶淀粉样变性:来自T70N溶菌酶结构与溶液动力学的见解
J Mol Biol. 2005 Sep 30;352(4):823-36. doi: 10.1016/j.jmb.2005.07.040.
6
Identification of the core structure of lysozyme amyloid fibrils by proteolysis.通过蛋白水解鉴定溶菌酶淀粉样纤维的核心结构
J Mol Biol. 2006 Aug 18;361(3):551-61. doi: 10.1016/j.jmb.2006.06.055. Epub 2006 Jul 7.
7
Cooperative folding of the isolated alpha-helical domain of hen egg-white lysozyme.鸡蛋清溶菌酶分离的α-螺旋结构域的协同折叠
J Mol Biol. 2001 Nov 23;314(2):321-9. doi: 10.1006/jmbi.2001.5122.
8
Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain.野生型鸡溶菌酶和β结构域肽片段形成淀粉样原纤维及接种
J Mol Biol. 2000 Jul 14;300(3):541-9. doi: 10.1006/jmbi.2000.3862.
9
Simulations of human lysozyme: probing the conformations triggering amyloidosis.人溶菌酶的模拟:探索引发淀粉样变性的构象
Biophys J. 2003 Apr;84(4):2149-58. doi: 10.1016/S0006-3495(03)75021-8.
10
Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants.正常与异常生物自组装:来自人类溶菌酶及其淀粉样变变体研究的见解
Acc Chem Res. 2006 Sep;39(9):603-10. doi: 10.1021/ar050070g.

引用本文的文献

1
Impact of Phenolic Compounds on Fibrillogenesis of Human Lysozyme under Physiological Conditions: Inhibition or Promotion?生理条件下酚类化合物对人溶菌酶原纤维形成的影响:抑制还是促进?
ACS Omega. 2025 Aug 5;10(32):35842-35849. doi: 10.1021/acsomega.5c02787. eCollection 2025 Aug 19.
2
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis.遗传性淀粉样变性中溶菌酶衍生的淀粉样纤维的冷冻电镜结构。
Nat Commun. 2024 Nov 7;15(1):9648. doi: 10.1038/s41467-024-54091-7.
3
Doxorubicin as a Drug Repurposing for Disruption of α-Chymotrypsinogen-A Aggregates.
多柔比星作为一种药物再利用,用于破坏α-糜蛋白酶原-A 聚集体。
Protein J. 2024 Aug;43(4):842-857. doi: 10.1007/s10930-024-10217-w. Epub 2024 Jul 16.
4
Raman Spectroscopic Insights of Phase-Separated Insulin Aggregates.相分离胰岛素聚集体的拉曼光谱洞察
ACS Phys Chem Au. 2024 Feb 15;4(3):268-280. doi: 10.1021/acsphyschemau.3c00065. eCollection 2024 May 22.
5
Effect of pH on the Poly(acrylic acid)/Poly(vinyl alcohol)/Lysozyme Complexes Formation.pH 对聚(丙烯酸)/聚(乙烯醇)/溶菌酶复合物形成的影响。
Molecules. 2023 Dec 29;29(1):208. doi: 10.3390/molecules29010208.
6
Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller.β -propeller 形成淀粉样蛋白中内部展开与致病聚集的竞争。
Nat Commun. 2024 Jan 2;15(1):155. doi: 10.1038/s41467-023-44479-2.
7
Investigating lysozyme amyloid fibril formation and structural variability dependence on its initial folding state under different pH conditions.研究溶菌酶淀粉样纤维形成及其结构可变性对不同 pH 值条件下初始折叠状态的依赖性。
Protein Sci. 2024 Feb;33(2):e4888. doi: 10.1002/pro.4888.
8
Energy Landscapes and Heat Capacity Signatures for Monomers and Dimers of Amyloid-Forming Hexapeptides.淀粉样肽单体和二聚体的能量景观和热容特征。
Int J Mol Sci. 2023 Jun 25;24(13):10613. doi: 10.3390/ijms241310613.
9
Analyses of Mutation Displacements from Homology Models.同源模型突变位移分析。
Methods Mol Biol. 2023;2627:195-210. doi: 10.1007/978-1-0716-2974-1_11.
10
The Ability of Some Polysaccharides to Disaggregate Lysozyme Amyloid Fibrils and Renature the Protein.某些多糖解聚溶菌酶淀粉样纤维并使蛋白质复性的能力。
Pharmaceutics. 2023 Feb 13;15(2):624. doi: 10.3390/pharmaceutics15020624.